NFCR’S ROLE

The National Foundation for Cancer Research has been a dedicated partner to the GBM AGILE initiative, since its conception and continues to be a valued member of the Global Coalition for Adaptive Research (GCAR), heavily engaged in the design, execution, and further expansion of GBM AGILE. 

NFCR’s History of Support:

  • Founding member of the National Biomarker Development Alliance, GBM AGILE’s initial sponsor
  • Original strategic partner to GCAR, GBM AGILE’s current sponsor 
  • Leading financier of GBM AGILE’s efforts to date 
  • Founder of multiple researchers whose work is pertinent to glioblastoma and whose input greatly benefits GBM AGILE
  • Complementary stakeholders and principals: 
      • Sujuan Ba, Ph.D., the NFCR President, is a member of the GCAR Board of Directors and a member of the GBM AGILE Knowledge Network’s executive committee
      • Michael Wang, Ph.D., the NFCR Chief Strategy Officer, is a member of the GBM AGILE Knowledge Network’s executive committee
      • Webster Cavenee, Ph.D., the chairman of NFCR’s Scientific Advisory Board, is one of the GBM AGILE concept’s three original visionaries, GCAR’s Chief Scientific Officer and a member of the GBM AGILE Knowledge Network’s executive committee
      • W.K. Alfred Yung, M.D., a former NFCR fellow, is one of the GBM AGILE concept’s three original visionaries, GCAR’s Executive Vice President for International Collaborations and a member of the GBM AGILE Knowledge Network’s executive committee